| Identification | Back Directory | [Name]
Benzamide, N-[2-(1-ethyl-4-piperidinyl)-1-(4-fluorophenyl)ethyl]-4-nitro- | [CAS]
1276186-19-6 | [Synonyms]
cavutilide
Benzamide, N-[2-(1-ethyl-4-piperidinyl)-1-(4-fluorophenyl)ethyl]-4-nitro- | [Molecular Formula]
C22H26FN3O3 | [MOL File]
1276186-19-6.mol | [Molecular Weight]
399.46 |
| Hazard Information | Back Directory | [Uses]
Cavutilide (Niferidil) is a class III antiarrhythmic agent that inhibits hERG K+ channel. Cavutilide has the potential for the study of persistent atrial fibrillation[1][2]. | [References]
[1] WHO Drug Information, Vol. 36, No. 2, 2022.
[2] Abramochkin DV, et al. Characterization of hERG K+ channel inhibition by the new class III antiarrhythmic drug cavutilide. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):5093-5104. DOI:10.1007/s00210-023-02940-5 |
|
|